Furthermore, several studies have indicated the potential predictive value of serum KL-6 in determining the prognosis of individuals with severe lung conditions, including idiopathic pulmonary fibrosis [17], and COVID-19 [18]. This evidence concerns the gene MUC1 and COVID-19.